Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
about
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesAssociation of liver enzymes and computed tomography markers of liver steatosis with familial longevityAssociation of liver enzymes with incident type 2 diabetes: A nested case control study in an Iranian populationObesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population.Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver diseaseInverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in MenMarkers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients.Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change.Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam study.RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in ratsAlanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulationAlanine aminotransferase within reference range is associated with metabolic syndrome in middle-aged and elderly Chinese men and womenDifferential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children.Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.Visceral abdominal and subfascial femoral adipose tissue have opposite associations with liver fat in overweight and obese premenopausal caucasian womenA novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice.Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RTEmerging applications of metabolomic and genomic profiling in diabetic clinical medicine.Waist-to-height ratio is more closely associated with alanine aminotransferase levels than body mass index and waist circumference among population-based children: a cross-sectional study in JapanRisk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetesDevelopment and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patientsAlanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults.Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control.Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Metabolic Syndrome and Serum Liver Enzymes in the General Chinese PopulationAnthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels?Association Between LYPLAL1 rs12137855 Polymorphism With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease in a Chinese Han Population.Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease.Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart StudyCentral body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.Impact of a High-Fat or High-Fiber Diet on Intestinal Microbiota and Metabolic Markers in a Pig Model
P2860
Q26828855-A90D18BA-D54B-469A-9C62-5598DB465688Q28540897-49D3A365-C6AD-4468-85D9-937723D8F36FQ33340725-2FA98C68-5BA8-424A-8BA8-D9E1F6399222Q33580624-A7246EF2-8312-4DA0-B4DE-3208D2545C7CQ33603540-D928DD81-5174-4D6E-881E-E49E8E4DEE21Q33607697-A3255189-C63C-4329-B397-6459EF851AE6Q33734975-5177D6F3-8CFA-4191-A1B0-31FB4B9175BFQ34405598-4549EB69-E1B6-4751-A95B-30D19D7CB4E2Q34411957-96AF7C85-854A-4967-8163-EF050ACAC4D6Q34471950-0C6F490F-127D-455D-BE67-2B754C6595F5Q34586384-C44FFBB1-91E3-40FF-8EBC-CC26EB4C453DQ34592729-69067CFF-740F-4DFC-9263-0B371576FF05Q34773457-4FEDB09E-056B-4208-A05F-1EE9A88E6E55Q34804363-A96810DB-38DA-4316-976D-5D3F581CF947Q35102868-45EADA45-263C-4C82-9EA7-83FD9316D596Q35159698-43AD2206-B727-498A-9367-893D1BD01DB5Q35231804-6DBBDDFE-8FED-430A-A1C0-21D351EDE6DDQ35319384-E8C8B1D7-18F0-49F4-88CC-8A6BB4E63546Q35543638-6CA3F924-6FE0-49DD-BC4A-6FD347E0A2A0Q35563714-730C9652-8163-4C1C-88DC-8ECBA82D385FQ35633290-4D4EF71E-3660-437E-AFA0-0032E035FAA2Q35711956-8F72AD72-7C50-4391-8337-C2C2D256DB67Q35819955-631C66C9-0E40-4D4D-9CAA-0032CC715D8FQ35833048-1401F6E4-8609-448D-B69A-7F25E3B8DACDQ35844102-3944648C-8F2A-41C6-BC91-851CAE0DF703Q35980112-DB8182FB-65F1-48E9-8F81-970023B9C17AQ35997312-7F980375-B6D6-44A7-B231-4E049133CAE1Q36144444-8B52D247-2615-4F09-BC7F-CCA7496F1359Q36402904-D35A44AC-9619-4777-BD14-A691DB28FA1AQ36436401-3BCD8866-0E34-4980-A13C-2A70D4D94E08Q36439605-B76B1A91-88BD-48F6-A6A1-EF5EB235FE20Q36470320-AD3DA6F5-950B-4E66-982C-71D9A94BF357Q36633937-C554EFA7-B0A4-4C7B-82E3-AF999BDFEA80Q36633948-E2066D0B-362C-43B1-AB6D-F4C472268FA0Q36634146-8607D9B5-C258-43C2-82F3-57CE79D5E667Q36699028-9ED5A8D9-54AE-4BF9-8440-B892910EF12CQ36800964-BC5E6EBD-D66D-4CD0-A983-0E4B451DAEECQ36807854-0C9BBBC6-BE1B-4F0B-A723-DD5CE2392CD5Q36880394-28E96BF0-BC52-40D1-A9B7-B1C33206934FQ36941910-76BE2C93-8DA3-4646-B6A4-3295AF5E3CC2
P2860
Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Alanine aminotransferase as a ...... us and cardiovascular disease.
@ast
Alanine aminotransferase as a ...... us and cardiovascular disease.
@en
type
label
Alanine aminotransferase as a ...... us and cardiovascular disease.
@ast
Alanine aminotransferase as a ...... us and cardiovascular disease.
@en
prefLabel
Alanine aminotransferase as a ...... us and cardiovascular disease.
@ast
Alanine aminotransferase as a ...... us and cardiovascular disease.
@en
P2093
P2860
P356
P1476
Alanine aminotransferase as a ...... us and cardiovascular disease.
@en
P2093
Maarten E Tushuizen
Michaela Diamant
Roger K Schindhelm
Tom Teerlink
P2860
P304
P356
10.1002/DMRR.666
P577
2006-11-01T00:00:00Z